艾普雷米拉斯特的安全性评估:来自FAERS数据库的现实世界不良事件分析
Landong Ren1, Kaidi Zhao1, Bingqing Wang1
1Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.
Archives of dermatological research
|April 8, 2025
概括
这项对阿普雷米拉斯特 (一种化酶4抑制剂) 的现实研究在超过124,000份报告中发现了新的潜在不良事件,包括吐和抑郁症,超出其已知的副作用.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 免疫调节疗法是一种免疫调节疗法.
背景情况:
- 阿普雷米拉斯特是一种口服化酶4抑制剂,已批准用于牛皮和牛皮性关节炎.
- 在大群体中使用阿普雷米拉斯的现实安全数据有限.
- 了解阿普雷米拉斯特的安全概况对于临床实践至关重要.
研究的目的:
- 为了评估apremilast的真实世界的安全概况.
- 使用大型不良事件数据库识别与阿普雷米拉斯特相关的潜在不良事件.
- 为了指导药物监测和临床使用apremilast.
主要方法:
- 利用FAERS数据库从2012年第一季度到2024年第一季度的不良事件报告.
- 分析了apremilast是主要可疑药物的报告.
- 使用多种不成比例分析方法 (ROR,PRR,BCPNN,MGPS).
主要成果:
- 分析了124,734份报告,其中阿普雷米拉斯作为主要可疑药物.
- 在27个器官系统类别中确定了252,677个对不良反应的首选术语.
- 除了标记事件外,还发现了新的潜在不良反应,包括吐,抑郁,自杀念头和减肥.
结论:
- 这项研究为Apremilast的现实世界使用提供了新的安全见解.
- 在药物标签上之前没有突出显示的临床相关的不良事件.
- 建立了一个框架,用于持续进行前期安全评估.
相关概念视频
01:19Pharmacovigilance
753
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
753
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:28Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
01:11Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
01:28Structure-Activity Relationships and Drug Design
461
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
461